Pathophysiology and Clinical Management of Fungal Infections

Dear Colleagues,

Fungal infections represent an escalating global health concern due to the rising prevalence of immunocompromised populations and the emerging threat of antifungal resistance. These infections range from superficial skin conditions to invasive, life-threatening systemic mycosis, affecting a diverse population globally but predominantly immunosuppressed individuals, including those with HIV/AIDS, cancer, or undergoing organ transplants. Understanding the pathophysiology of fungal infections is critical for developing targeted therapeutic strategies. Key areas of current research focus on the molecular and cellular processes that drive fungal pathogenicity, such as biofilm formation, and cellular differentiation processes, such as spore production and host invasion. Additionally, the role of the microbiome and host genetic factors in host–pathogen interactions and disease progression, and the modulation of immune responses hold paramount promise for novel therapeutic interventions. Clinical management remains challenging due to the lack of rapid and specific diagnosis, limited antifungal classes, and the rise of multidrug-resistant species. Therefore, advances in rapid diagnostics, such as molecular assays and biomarker-based tools, are critical for timely intervention. Therapeutically, there is growing interest in exploring combination antifungal regimens, drug repurposing, immunotherapies, and the development of new antifungal agents with novel mechanisms of action. We encourage submissions that provide insights into fungal biology, pathogenesis, diagnostic innovations, antifungal resistance mechanisms, and cutting-edge therapeutic advances, aiming to improve patient outcomes and expand our understanding and management of these complex infections.

Dr. Allan J. Guimarães
Dr. Marcos de Abreu Almeida
Topic Editors